IVD Clinical Trial Monitoring Should Be Higher Priority For Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
Developers of in vitro diagnostics should make the monitoring of investigators a key part of their clinical trial protocols, speakers at the Oct. 26-27 Association Medical Diagnostics Manufacturers' annual meeting in Rockville, Maryland cautioned.